Culturally and linguistically diverse patient participation in glioma research
Authors:
- Zarnie LwinZLZarnie Lwin
- Alexander BroomABAlexander Broom
- Ann LivingstoneALAnn Livingstone
- Emma KirbyEKEmma Kirby
- on behalf of the COGNO CALD working groupOGon behalf of the COGNO CALD working group
Open Access
- 25 June 2014
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
- Vol. 1 (3) , 101-105
Abstract
Marginal communities, such as culturally and linguistically diverse (CALD) patients, have significantly lower rates of recruitment, accrual, and retention in cancer clinical trials. A combination of language and cultural barriers means that trial participation from CALD communities remains at suboptimal levels, which in turn favors research findings that are biased towards therapeutic effects or toxicities within the context of non-CALD populations. Here we outline some key challenges and implications for CALD patient participation in glioma research in countries such as Australia, where English is the language of governance and health services implementation. We highlight multistakeholder interventions to improve both investigator recruitment and participation of CALD communities in future glioma research, particularly in this era when global migration has come of age. Enhancing research participation of CALD communities ensures not only wider understanding of genetic heterogeneity to improve glioma outcomes but also equity in access to care.Keywords
This publication has 58 references indexed in Scilit:
- Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825Neuro-Oncology, 2013
- Editor's noteNeuro-Oncology, 2012
- Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in IranHealth and Quality of Life Outcomes, 2012
- Interventions to improve patient participation in the treatment process for culturally and linguistically diverse people with cancer: A systematic reviewAsia-Pacific Journal of Clinical Oncology, 2012
- Grappling with cultural differences; Communication between oncologists and immigrant cancer patients with and without interpretersPatient Education and Counseling, 2011
- A bridge between cultures: interpreters’ perspectives of consultations with migrant oncology patientsSupportive Care in Cancer, 2010
- Caring for someone with high-grade glioma: a time of rapid change for caregiversPalliative Medicine, 2010
- Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic reviewCancer, 2007
- Why Are Ethnic Minorities Under-Represented in US Research Studies?PLOS Medicine, 2005
- Health-related quality of life in patients with glioblastoma: a randomised controlled trialThe Lancet Oncology, 2005